CA Stock MarketDetailed Quotes

ZYUS Life Sciences Corp (ZYUS)

Watchlist
  • 0.495
  • 0.0000.00%
15min DelayMarket Closed May 6 16:00 ET
39.64MMarket Cap-1.08P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ZYUS Life Sciences Corp (ZYUS) Revenue Breakdown Overview

By Business/Source

Currency:CAD
2024/FY
Stock NameRevenueRatio
Bio-pharmaceutical Products481K100.00%

By Product

No Data

By Industry

No Data

By Country/Region

Currency:CAD
2024/FY
Stock NameRevenueRatio
Canada481K100.00%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +2.64%
Sample Name
Sample Code
 -0.13%
Sample Name
Sample Code
 -1.05%
4
SHANGHAI PECHEM
00338
-1.56%
5
SINOPEC CORP
00386
-2.39%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +41.26%
Sample Name
Sample Code
 +31.66%
Sample Name
Sample Code
 +26.25%
4
Digital China Group
000034
+15.29%
5
Loongson Technology Corporation
688047
+12.74%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -